HUMAW

Conviction 0HealthcareScan · Mon, Aug 10, 2026

HUMAW$0.0080-11.11%

ResistanceSupportVol 14

Vol MA14 47.99K

May 8May 27Jun 15Jul 2Jul 22Aug 7

Humacyte, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.humacyte.com ↗

Price0.0080

Change-11.11%

Gap+0.00%

Rel volume0.04×

Avg volume35.16K

Avg $ vol339.52

SMA 200.0086

SMA 500.0185

SMA 2000.0903

Price vs 50-56.83%

Price vs 200-91.14%

MA stackbearish

50/200 cross—

Supertrenddown · 0.0110

RSI (14)45

MACD hist0.00

MACD cross—

Stoch %K / %D80 / 80

ADX (14)9

+DI / −DI28 / 31

RSI divergence—

MACD divergence—

ATR %+45.29%

ADR %12.89%

52w high0.4999

52w low0.0000

From 52w high-98.40%

Above 52w low—

New 52w highNo

SqueezeOn · 20d

Bollinger width100.57%

%B0.43

Donchian pos80.00%

Donchian high0.0100

Donchian low0.0000

AVWAP (52w high)0.1173

vs AVWAP high-93.18%

AVWAP (52w low)0.1063

vs AVWAP low-92.47%

OBV trendUp

Chaikin MF (20)0.77

Today vs 20d0.04×

Avg vol (14d)47.99K

Avg vol (20d)35.16K

Avg $ vol (20d)339.52

Market cap1.78M

RS 3m (vs SPY)-94.27%

RS 6m (vs SPY)-107.10%

RS line new highNo

Trend template0/8

Technical rank7.2

1 week-20.00%

1 month-15.79%

3 months-88.57%

6 months-92.98%

1 year-98.20%

YTD-91.97%

P/E-0.04

P/B0.15

P/S0.87

P/FCF-0.02

EPS-0.2600

Div yield—

ROE-351.28%

ROA-36.93%

Debt/Eq3.09

Current3.93

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth72.54%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-10.89M

Revenue495K

Net income-17.62M

Gross profit—

Free cash flow-105.93M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees184

ListedFri, Aug 27, 2021

Free float222.02M

Float %100.0%

Short interest3.75K

Days to cover0.2d

Short volume22.8%

Squeeze score1 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank7.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.0116

Support0.0024

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in HUMAW

All disclosures →

No recent disclosed trades by Congress in HUMAW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in HUMAW

No recent insider (Form 4) filings in HUMAW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in HUMAW

EDGAR →

No recent SEC filings on file for HUMAW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.